Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
6 tulemused
2-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor-.alpha. and neuroprotector of brain in closed head injury
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
1. The present invention relates to 2-arachidonylglycerol (2-AG) to be used as inhibitor of a tumor necrosis factor (TNF-.alpha.), in the reduction of edema caused by closed head injury, in the reduction of neurological deficits caused by closed head injury and stroke and in
Paramyxovirus vector encoding angiogenesis gene and use thereof
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates to Paramyxovirus vectors encoding angiogenesis genes and use thereof.
BACKGROUND OF THE INVENTION
Recent research for treatment of ischemic diseases has been performed using growth factors that induce angiogenesis. For example, the therapeutic
Composition for lipolysis, containing phosphatidylcholine, and preparation method therefor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
1. Field
Exemplary embodiments relate to a composition for inducing lipolysis comprising phosphatidylcholine and a preparation method thereof. More particularly, exemplary embodiments relate to a composition for lipolysis comprising 2-12% (w/v) of phosphatidylcholine, 5-12% (w/v) of an
Microcatheter and method for site specific therapy
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
In one aspect, the present invention relates to methods and apparatuses for treating microcirculatory problems, including transient and reversible conditions that do no involve structural injury, as well as permanent or chronic conditions that do involve structural injury to the
Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
The present invention relates to a method of promoting retinal neuron survival as well as preventing photoneuron degredation.
The retina is the light-sensitive portion of the eye. The retina contains the cones and rods (photoreceptors), the photosensitive cells. The rods contain
System and method for site specific therapy
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
In one aspect, the present invention relates to methods and apparatuses for treating microcirculatory problems, including transient and reversible conditions that do no involve structural injury, as well as permanent or chronic conditions that do involve structural injury to the
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
